382 related articles for article (PubMed ID: 18046530)
1. Catheter-ablation of ventricular tachycardia in patients with coronary artery disease: influence of the endocardial substrate size on clinical outcome.
Antz M; Berodt K; Bänsch D; Ernst S; Chun KJ; Satomi K; Schmidt B; Boczor S; Ouyang F; Kuck KH
Clin Res Cardiol; 2008 Feb; 97(2):110-7. PubMed ID: 18046530
[TBL] [Abstract][Full Text] [Related]
2. Substrate mapping vs. tachycardia mapping using CARTO in patients with coronary artery disease and ventricular tachycardia: impact on outcome of catheter ablation.
Volkmer M; Ouyang F; Deger F; Ernst S; Goya M; Bänsch D; Berodt K; Kuck KH; Antz M
Europace; 2006 Nov; 8(11):968-76. PubMed ID: 17043071
[TBL] [Abstract][Full Text] [Related]
3. Safety, long-term results, and predictors of recurrence after complete endocardial ventricular tachycardia substrate ablation in patients with previous myocardial infarction.
Arenal Á; Hernández J; Calvo D; Ceballos C; Atéa L; Datino T; Atienza F; González-Torrecilla E; Eídelman G; Miracle Á; Avila P; Bermejo J; Fernández-Avilés F
Am J Cardiol; 2013 Feb; 111(4):499-505. PubMed ID: 23228925
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of targeting catheter ablation to the markedly low-voltage area surrounding infarct scars in patients with post-infarction ventricular tachycardia.
Yoshida K; Sekiguchi Y; Tanoue K; Endo M; Suzuki A; Kanemoto M; Yamasaki H; Yamauchi Y; Takahashi A; Kuga K; Yamaguchi I; Aonuma K
Circ J; 2008 Jul; 72(7):1112-9. PubMed ID: 18577820
[TBL] [Abstract][Full Text] [Related]
5. Catheter ablation of arrhythmic storm triggered by monomorphic ectopic beats in patients with coronary artery disease.
Peichl P; Cihák R; Kozeluhová M; Wichterle D; Vancura V; Kautzner J
J Interv Card Electrophysiol; 2010 Jan; 27(1):51-9. PubMed ID: 19937101
[TBL] [Abstract][Full Text] [Related]
6. Electrical isolation of a substrate after myocardial infarction: a novel ablation strategy for unmappable ventricular tachycardias--feasibility and clinical outcome.
Tilz RR; Makimoto H; Lin T; Rillig A; Deiss S; Wissner E; Mathew S; Metzner A; Rausch P; Kuck KH; Ouyang F
Europace; 2014 Jul; 16(7):1040-52. PubMed ID: 24574495
[TBL] [Abstract][Full Text] [Related]
7. Relation of the unipolar low-voltage penumbra surrounding the endocardial low-voltage scar to ventricular tachycardia circuit sites and ablation outcomes in ischemic cardiomyopathy.
Chopra N; Tokuda M; Ng J; Reichlin T; Nof E; John RM; Tedrow UB; Stevenson WG
J Cardiovasc Electrophysiol; 2014 Jun; 25(6):602-8. PubMed ID: 24576211
[TBL] [Abstract][Full Text] [Related]
8. Nonischemic cardiomyopathy substrate and ventricular tachycardia in the setting of coronary artery disease.
Aldhoon B; Tzou WS; Riley MP; Lin D; Callans DJ; Hutchinson MD; Dixit S; Garcia FC; Zado ES; Marchlinski FE
Heart Rhythm; 2013 Nov; 10(11):1622-7. PubMed ID: 23973949
[TBL] [Abstract][Full Text] [Related]
9. Substrate-modification using electroanatomical mapping in sinus rhythm to treat ventricular tachycardia in patients with ischemic cardiomyopathy.
Deneke T; Grewe PH; Lawo T; Calcum B; Mügge A; Lemke B
Z Kardiol; 2005 Jul; 94(7):453-60. PubMed ID: 15997346
[TBL] [Abstract][Full Text] [Related]
10. Substrate Characterization and Outcome of Catheter Ablation of Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy and Isolated Epicardial Scar.
Liuba I; Muser D; Chahal A; Tschabrunn C; Santangeli P; Kuo L; Frankel DS; Callans DJ; Garcia F; Supple GE; Schaller RD; Dixit S; Lin D; Nazarian S; Kumareswaran R; Arkles J; Riley MP; Hyman MC; Walsh K; Guandalini G; Arceluz M; Pothineni NVK; Zado ES; Marchlinski F
Circ Arrhythm Electrophysiol; 2021 Dec; 14(12):e010279. PubMed ID: 34847692
[TBL] [Abstract][Full Text] [Related]
11. Combined analysis of unipolar and bipolar voltage mapping identifies recurrences after unmappable scar-related ventricular tachycardia ablation.
Yalin K; Golcuk E; Bilge AK; Aksu T; Buyukbayrak H; Tiryakioglu SK; Emet S; Adalet K
Europace; 2015 Oct; 17(10):1580-6. PubMed ID: 25750215
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Hidden Substrate Unmasked by Right Ventricular Extrastimulation Improves Ventricular Tachycardia Ablation Outcome After Myocardial Infarction.
de Riva M; Naruse Y; Ebert M; Androulakis AFA; Tao Q; Watanabe M; Wijnmaalen AP; Venlet J; Brouwer C; Trines SA; Schalij MJ; Zeppenfeld K
JACC Clin Electrophysiol; 2018 Mar; 4(3):316-327. PubMed ID: 30089556
[TBL] [Abstract][Full Text] [Related]
13. Noninducibility and late potential abolition: a novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia.
Silberbauer J; Oloriz T; Maccabelli G; Tsiachris D; Baratto F; Vergara P; Mizuno H; Bisceglia C; Marzi A; Sora N; Guarracini F; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):424-35. PubMed ID: 24833642
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia.
Nakahara S; Tung R; Ramirez RJ; Michowitz Y; Vaseghi M; Buch E; Gima J; Wiener I; Mahajan A; Boyle NG; Shivkumar K
J Am Coll Cardiol; 2010 May; 55(21):2355-65. PubMed ID: 20488307
[TBL] [Abstract][Full Text] [Related]
15. Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study).
Kuck KH; Tilz RR; Deneke T; Hoffmann BA; Ventura R; Hansen PS; Zarse M; Hohnloser SH; Kautzner J; Willems S;
Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292751
[TBL] [Abstract][Full Text] [Related]
16. Catheter ablation of ventricular tachycardias in patients with ischemic cardiomyopathy: validation of voltage mapping criteria for substrate modification by myocardial viability assessment using FDG PET.
Kettering K; Weig HJ; Reimold M; Schwegler AC; Busch M; Laszlo R; Gawaz M; Schreieck J
Clin Res Cardiol; 2010 Nov; 99(11):753-60. PubMed ID: 20532538
[TBL] [Abstract][Full Text] [Related]
17. Electroanatomical voltage and morphology characteristics in postinfarction patients undergoing ventricular tachycardia ablation: pragmatic approach favoring late potentials abolition.
Tsiachris D; Silberbauer J; Maccabelli G; Oloriz T; Baratto F; Mizuno H; Bisceglia C; Vergara P; Marzi A; Sora N; Guarracini F; Radinovic A; Cireddu M; Sala S; Gulletta S; Paglino G; Mazzone P; Trevisi N; Della Bella P
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):863-73. PubMed ID: 26022186
[TBL] [Abstract][Full Text] [Related]
18. Catheter ablation of stable and unstable ventricular tachycardias in patients with arrhythmogenic right ventricular dysplasia.
Satomi K; Kurita T; Suyama K; Noda T; Okamura H; Otomo K; Shimizu W; Aihara N; Kamakura S
J Cardiovasc Electrophysiol; 2006 May; 17(5):469-76. PubMed ID: 16684016
[TBL] [Abstract][Full Text] [Related]
19. Larger low voltage zone in endocardial unipolar map compared with that in epicardial bipolar map indicates difficulty in eliminating ventricular tachycardia by catheter ablation.
Miyamoto K; Noda T; Satomi K; Wada M; Nakajima I; Ishibashi K; Okamura H; Noguchi T; Anzai T; Yasuda S; Ogawa H; Shimizu W; Aiba T; Kamakura S; Kusano K
Heart Vessels; 2016 Aug; 31(8):1337-46. PubMed ID: 26266635
[TBL] [Abstract][Full Text] [Related]
20. Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Garcia FC; Bazan V; Zado ES; Ren JF; Marchlinski FE
Circulation; 2009 Aug; 120(5):366-75. PubMed ID: 19620503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
